Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRONOMOS
2015-000981-70Phase 3Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in venous thromboembolism (VTE) comparing Rivaroxaban arm with Enoxaparin arm (2 arms). Primary endpoint: Major venous thromboembolism. Started Jan 2016; status: completed.
02
Drugs
rivaroxabanenoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2015-000981-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000981-70.